Thaddeus J. Unger

2.2k total citations
17 papers, 1.4k citations indexed

About

Thaddeus J. Unger is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Thaddeus J. Unger has authored 17 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Hematology and 4 papers in Oncology. Recurrent topics in Thaddeus J. Unger's work include Multiple Myeloma Research and Treatments (5 papers), Nuclear Structure and Function (5 papers) and Nerve injury and regeneration (3 papers). Thaddeus J. Unger is often cited by papers focused on Multiple Myeloma Research and Treatments (5 papers), Nuclear Structure and Function (5 papers) and Nerve injury and regeneration (3 papers). Thaddeus J. Unger collaborates with scholars based in United States, Canada and Denmark. Thaddeus J. Unger's co-authors include Maribel Rios, Leila Bradley, Miguel Sena‐Esteves, Germán Calderón, Sharon Shacham, Michael Kauffman, Yosef Landesman, Morten Mau‐Sørensen, Tami Rashal and Nashat Gabrail and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and Blood.

In The Last Decade

Thaddeus J. Unger

17 papers receiving 1.4k citations

Peers

Countries citing papers authored by Thaddeus J. Unger

Since Specialization

Citations

This map shows the geographic impact of Thaddeus J. Unger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thaddeus J. Unger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thaddeus J. Unger more than expected).

Fields of papers citing papers by Thaddeus J. Unger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thaddeus J. Unger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thaddeus J. Unger. The network helps show where Thaddeus J. Unger may publish in the future.

Co-authorship network of co-authors of Thaddeus J. Unger

This figure shows the co-authorship network connecting the top 25 collaborators of Thaddeus J. Unger. A scholar is included among the top collaborators of Thaddeus J. Unger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thaddeus J. Unger. Thaddeus J. Unger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Targeting PAK4 Inhibits Ras-Mediated Signaling and Multiple Oncogenic Pathways in High-Risk Rhabdomyosarcoma 2020 ·Cancer Research ·(unknown), Laura Sierra, (unknown), Lyazat Kurenbekova, (unknown), (unknown), Ryan L. Shuck, Nino Rainusso, Yosef Landesman, Thaddeus J. Unger, Cristian Coarfa, Jason T. Yustein	29
2	Selinexor‐based regimens for the treatment of myeloma refractory to chimeric antigen receptor T cell therapy 2020 ·British Journal of Haematology ·Ajai Chari, Dan T. Vogl, Sundar Jagannath, Jagoda Jasielec, Thaddeus J. Unger, Andrew DeCastro, Jatin J. Shah, Michael Kauffman, Sharon Shacham, Andrzej Jakubowiak	12
3	Clinical Implications of Targeting XPO1-mediated Nuclear Export in Multiple Myeloma 2018 ·Clinical Lymphoma Myeloma & Leukemia ·Ujjawal H. Gandhi, William Senapedis, Erkan Baloglu, Thaddeus J. Unger, Ajai Chari, Dan T. Vogl, Robert F. Cornell	75
4	Selinexor plus low-dose bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma 2018 ·Blood ·Nizar J. Bahlis, Heather J. Sutherland, Darrell White, Michaël Sébag, Suzanne Lentzsch, Rami Kotb, Christopher P. Venner, Cristina Gasparetto, Aldo Del Col, Paola Neri, Donna Reece, Michael Kauffman, Sharon Shacham, Thaddeus J. Unger, Jacqueline Jeha, Jean‐Richard Saint‐Martin, Jatin J. Shah, Christine Chen	102
5	Selinexor synergizes with dexamethasone to repress mTORC1 signaling and induce multiple myeloma cell death 2018 ·Oncotarget ·Christian Argueta, Trinayan Kashyap, Boris Klebanov, Thaddeus J. Unger, (unknown), (unknown), Erkan Baloglu, Margaret Lee, William Senapedis, Sharon Shacham, Yosef Landesman	29
6	Selinexor reduces the expression of DNA damage repair proteins and sensitizes cancer cells to DNA damaging agents 2018 ·Oncotarget ·Trinayan Kashyap, Christian Argueta, Thaddeus J. Unger, Boris Klebanov, (unknown), William Senapedis, Marsha Crochiere, Margaret Lee, Michael Kauffman, Sharon Shacham, Yosef Landesman	35
7	Selective inhibition of nuclear export with selinexor in patients with non-Hodgkin lymphoma 2017 ·Blood ·John Kuruvilla, Michael R. Savona, Rachid Baz, Morten Mau‐Sørensen, Nashat Gabrail, Ramiro Garzon, Richard M. Stone, Michael Wang, Lynn Savoie, Peter Martin, Ian W. Flinn, Meagan A. Jacoby, Thaddeus J. Unger, Jean-Richard Saint-Martin, Tami Rashal, Sharon Friedlander, Robert Carlson, Michael Kauffman, Sharon Shacham, Martin Gutierrez	112
8	A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia 2017 ·Blood ·Ramiro Garzon, Michael R. Savona, Rachid Baz, Michael Andreeff, Nashat Gabrail, Martin Gutierrez, Lynn Savoie, Morten Mau‐Sørensen, (unknown), Karen Yee, Thaddeus J. Unger, Jean-Richard Saint-Martin, Robert Carlson, Tami Rashal, Trinayan Kashyap, Boris Klebanov, Sharon Shacham, Michael Kauffman, Richard M. Stone	102
9	Selinexor-induced thrombocytopenia results from inhibition of thrombopoietin signaling in early megakaryopoiesis 2017 ·Blood ·Kellie R. Machlus, Stephen Wu, (unknown), (unknown), Zhijian Liu, (unknown), Thaddeus J. Unger, Trinayan Kashyap, Boris Klebanov, Martha Sola‐Visner, Marsha Crochiere, Joseph E. Italiano, Yosef Landesman	55
10	Safety and efficacy of selinexor in relapsed or refractory multiple myeloma and Waldenstrom macroglobulinemia 2017 ·Blood ·Christine Chen, David S. Siegel, Martin Gutierrez, Meagan A. Jacoby, Craig C. Hofmeister, Nashat Gabrail, Rachid Baz, Morten Mau‐Sørensen, Jesús G. Berdeja, Michael R. Savona, Lynn Savoie, Suzanne Trudel, (unknown), Thaddeus J. Unger, Tami Rashal, (unknown), Michael Kauffman, Sharon Shacham, Donna Reece	101
11	Selinexor, a Selective Inhibitor of Nuclear Export (SINE) compound, acts through NF-κB deactivation and combines with proteasome inhibitors to synergistically induce tumor cell death 2016 ·Oncotarget ·Trinayan Kashyap, Christian Argueta, Amro Aboukameel, Thaddeus J. Unger, Boris Klebanov, Ramzi M. Mohammad, Irfana Muqbil, Asfar S. Azmi, (unknown), William Senapedis, Margaret Lee, Michael Kauffman, Sharon Shacham, Yosef Landesman	91
12	First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid Tumors 2016 ·Journal of Clinical Oncology ·Albiruni R. Abdul Razak, Morten Mau‐Sørensen, Nashat Gabrail, John F. Gerecitano, Anthony F. Shields, Thaddeus J. Unger, (unknown), Robert Carlson, Yosef Landesman, Dilara McCauley, Tami Rashal, Ulrik Lassen, Richard Kim, (unknown), Mansoor Raza Mirza, Michael Kauffman, Sharon Shacham, Amit Mahipal	180
13	Antiobesity Effect of a Small Molecule Repressor of RORγ 2015 ·Molecular Pharmacology ·Mi Ra Chang, Yuanjun He, Tanya Khan, Dana S. Kuruvilla, Rubén D. Garcia-Ordoñez, Cesar A. Corzo, Thaddeus J. Unger, David W. White, Susan Khan, Li Lin, Michael D. Cameron, Theodore M. Kamenecka, Patrick R. Griffin	33
14	Activation of TrkB with TAM-163 Results in Opposite Effects on Body Weight in Rodents and Non-Human Primates 2013 ·PLoS ONE ·Mylène Perreault, Feng Guo, Sarah Will, (unknown), (unknown), Kimberly Marquette, Yulia Vugmeyster, Thaddeus J. Unger, Juli E. Jones, Ariful Qadri, Seung Hahm, Ying Sun, Cynthia M. Rohde, (unknown), Janet Paulsen, Ruth E. Gimeno	21
15	Selective Deletion ofBdnfin the Ventromedial and Dorsomedial Hypothalamus of Adult Mice Results in Hyperphagic Behavior and Obesity 2007 ·Journal of Neuroscience ·Thaddeus J. Unger, Germán Calderón, Leila Bradley, Miguel Sena‐Esteves, Maribel Rios	301
16	Examination of behavioral deficits triggered by targeting BDNF in fetal or postnatal brains of mice 2006 ·Neuroscience ·Jason Chan, Thaddeus J. Unger, John Byrnes, Maribel Rios	95
17	Brain angiotensin II: localization and possible functions. 1987 ·PubMed ·Rainer Rettig, Detlev Ganten, (unknown), Thaddeus J. Unger	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact